Skip to main content
Clinical Trials/NL-OMON42765
NL-OMON42765
Completed
Not Applicable

ongitudinal analysis of head and neck cancer-specific immunity in patients treated with (salvage) surgery - Tumor-specific immunity in HNSCC treated with surgery

Antoni van Leeuwenhoek Ziekenhuis0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
head and neck cancer
Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Antoni van Leeuwenhoek Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • a. Histologically proven HPV positive or negative HNSCC with an indication for (salvage) surgery with/without adjuvant (C)RT in a curative setting
  • b. Tumor site: oral cavity, and in case of salvage surgery: all sites
  • c. Age above 18 years
  • d. Performance score WHO 0,1 or 2 at time of study entry
  • e. Written ICF

Exclusion Criteria

  • a. The use of immunosuppressive drugs at start of the treatment
  • b. Anemia \< 6\.0 mmol/L
  • c. In case of disease relapse or progression: Any bleeding disorder or anti\-coagulation therapy, that cannot be discontinued or corrected, that significantly increases the risk of a bleeding due to the biopsy.

Outcomes

Primary Outcomes

Not specified

Similar Trials